P1188: PERSONALIZED TREATMENT ACCORDING TO BIOLOGICAL PROFILE IMPROVES OUTCOME OF NEWLY DIAGNOSED PATIENTS AFFECTED BY DIFFUSE LARGE B-CELL LYMPHOMA: A REAL-LIFE EXPERIENCE

por Guidetti, A., Pasquale, R., Dodero, A., Chiappella, A., Devizzi, L., Farina, L., Rusconi, C., Pennisi, M., Corradini, P.
Publicado 2022

First salvage treatment with bendamustine and brentuximab vedotin in Hodgkin lymphoma: a phase 2 study of the Fondazione Italiana Linfomi

por Broccoli, A., Argnani, L., Botto, B., Corradini, P., Pinto, A., Re, A., Vitolo, U., Fanti, S., Stefoni, V., Zinzani, P. L.
Publicado 2019

P1174: THE COMBINATION OF QUALITATIVE AND QUANTITATIVE METABOLIC PARAMETERS PREDICTS PROGRESSION-FREE SURVIVAL IN PATIENTS WITH LARGE B-CELL LYMPHOMAS (LBCL) TREATED WITH ANTI-CD19...

por Dodero, A., Guidetti, A., Lorenzoni, A., Pizzamiglio, S., Argiroffi, G., Verderio, P., Chiappella, A., Bagnoli, F., Carniti, C., Pennisi, M., Alessi, A., Corradini, P.
Publicado 2022

High-dose chemotherapy followed by autologous transplantation may overcome the poor prognosis of diffuse large B-cell lymphoma patients with MYC/BCL2 co-expression

por Maura, F, Guidetti, A, Pellegrinelli, A, Dodero, A, Pennisi, M, Caprioli, C, Testi, A, Farina, L, Bolli, N, Devizzi, L F, Cabras, A, Corradini, P
Publicado 2017

Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma

por Dodero, A., Guidetti, A., Tucci, A., Barretta, F., Novo, M., Devizzi, L., Re, A., Passi, A., Pellegrinelli, A., Pruneri, G., Miceli, R., Testi, A., Pennisi, M., Di Chio, M. C., Matteucci, P., Carniti, C., Facchetti, F., Rossi, G., Corradini, P.
Publicado 2019

P932: ON-DEMAND PLERIXAFOR WITH CYCLOPHOSPHAMIDE AND G-CSF FOR HEMATOPOIETIC STEM-CELL MOBILIZATION IN MULTIPLE MYELOMA PATIENTS: FINAL RESULTS OF THE MOZOBL06877 STUDY

por Mina, R., Bonello, F., Fazio, F., Saccardi, R., Bongarzoni, V., Marchesi, F., Bertuglia, G., Curci, P., Lemoli, R. M., Ballanti, S., Dentamaro, T., Benevolo, G., Capra, A., Floris, R., Tosi, P., Olivieri, A., Rota-Scalabrini, D., Cangialosi, C., Cavo, M., Corradini, P., Milone, G., Boccadoro, M., Larocca, A.
Publicado 2022

Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patients

por Rambaldi, A, Bacigalupo, A, Fanin, R, Ciceri, F, Bonifazi, F, Falda, M, Lambertenghi-Deliliers, G, Benedetti, F, Bruno, B, Corradini, P, Alessandrino, P E, Iacopino, P, Arcese, W, Scimè, R, Raimondi, R, Sica, S, Castagna, L, Lamparelli, T, Oneto, R, Lombardini, L, Pollichieni, S, Algarotti, A, Carobbio, A, Sacchi, N, Bosi, A
Publicado 2012

The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospectiv...

por Todisco, E, Ciceri, F, Oldani, E, Boschini, C, Micò, C, VanLint, M T, Donnini, I, Patriarca, F, Alessandrino, P E, Bonifazi, F, Arcese, W, Barberi, W, Marenco, P, Terruzzi, E, Cortelazzo, S, Santarone, S, Proia, A, Corradini, P, Tagliaferri, E, Falcioni, S, Irrera, G, Dallanegra, L, Castagna, L, Santoro, A, Camboni, A, Sacchi, N, Bosi, A, Bacigalupo, A, Rambaldi, A
Publicado 2013

Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines

por Maura, F, Petljak, M, Lionetti, M, Cifola, I, Liang, W, Pinatel, E, Alexandrov, L B, Fullam, A, Martincorena, I, Dawson, K J, Angelopoulos, N, Samur, M K, Szalat, R, Zamora, J, Tarpey, P, Davies, H, Corradini, P, Anderson, K C, Minvielle, S, Neri, A, Avet-Loiseau, H, Keats, J, Campbell, P J, Munshi, N C, Bolli, N
Publicado 2018

Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus

por Buske, C., Dreyling, M., Alvarez-Larrán, A., Apperley, J., Arcaini, L., Besson, C., Bullinger, L., Corradini, P., Giovanni Della Porta, M., Dimopoulos, M., D’Sa, S., Eich, H.T., Foà, R., Ghia, P., da Silva, M.G., Gribben, J., Hajek, R., Harrison, C., Heuser, M., Kiesewetter, B., Kiladjian, J.J., Kröger, N., Moreau, P., Passweg, J.R., Peyvandi, F., Rea, D., Ribera, J.-M., Robak, T., San-Miguel, J.F., Santini, V., Sanz, G., Sonneveld, P., von Lilienfeld-Toal, M., Wendtner, C., Pentheroudakis, G., Passamonti, F.
Publicado 2022

P1144: RADIOIMMUNOTHERAPY (RIT) VERSUS AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION (ASCT) IN RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA: A FONDAZIONE ITALIANA LINFOMI (FI...

por Ladetto, M., Tavarozzi, R., Evangelista, A., Zanni, M., Tucci, A., Anastasia, A., Botto, B., Boccomini, C., Bolis, S., Volpetti, S., Zilioli, V. R., Puccini, B., Arcari, A., Pavone, V., Gaidano, G., Corradini, P., Tani, M., Ferrero, S., Cavallo, F., Milone, G., Ghiggi, C., Pinto, A., Pastore, D., Ferreri, A. J., Latte, G., Patti, C., Re, F., Arcaini, L., Benedetti, F., Usai, S. V., Luminari, S., Mannina, D., Pulsoni, A., Stelitano, C., Pennese, E., Pietrantuono, G., Gherlinzoni, F., Pomponi, F., Olivieri, A., Perrone, T., Rota Scalabrini, D., Califano, C., Falini, B., Ciccone, G., Vitolo, U.
Publicado 2022